South Korea’s Celltrion says tapped to buy US pharma factory to offset tariff risk
SEOUL (Reuters) -South Korean pharmaceutical firm Celltrion said on Tuesday that in an attempt to offset the risk of U.S. ...
Read moreDetailsSEOUL (Reuters) -South Korean pharmaceutical firm Celltrion said on Tuesday that in an attempt to offset the risk of U.S. ...
Read moreDetails
